Trial Information
AVIDA The Vidaza® (Azacitidine) Patient Registry
Inclusion Criteria:
- Patient who is deemed appropriate for treatment with Vidaza® by his or her clinician,
but who has not already started receiving Vidaza® treatment.
- Patient who is able to read and speak English.
- Patient who is willing and able to provide informed consent.
- Patient who agrees to complete patient assessment questionnaires.
Exclusion Criteria:
- Patients who are currently being treated with Vidaza®.
- Patients who are concurrently participating in a clinical trial.
- Patients unwilling or unable to complete the baseline and follow-up questionnaires.
- Patients who are deemed inappropriate for treatment with Vidaza®.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
David L. Grinblatt, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
NorthShore University HealthSystem Research Institute
Authority:
United States: Institutional Review Board
Study ID:
AVIDA
NCT ID:
NCT00481273
Start Date:
October 2006
Completion Date:
June 2010
Related Keywords:
- Myelodysplastic Syndromes
- MDS
- Myelodysplastic Syndromes
- Preleukemia
Name | Location |
AVIDA Registry Help |
Kansas City, Missouri 66210 |